Liu YX - Search Results

1

Transforming Growth Factor-β Receptor III is a Potential Regulator of Ischemia-Induced Cardiomyocyte Apoptosis.

Sun F, Li X, Duan WQ, Tian W, Gao M, Yang J, Wu XY, Huang D, Xia W, Han YN, Wang JX, Liu YX, Dong CJ, Zhao D, Ban T, Chu WF. Sun F, et al. Among authors: liu yx. J Am Heart Assoc. 2017 May 30;6(6):e005357. doi: 10.1161/JAHA.116.005357. J Am Heart Assoc. 2017. PMID: 28559372 Free PMC article.

2

MicroRNA-328, a Potential Anti-Fibrotic Target in Cardiac Interstitial Fibrosis.

Du W, Liang H, Gao X, Li X, Zhang Y, Pan Z, Li C, Wang Y, Liu Y, Yuan W, Ma N, Chu W, Shan H, Lu Y. Du W, et al. Cell Physiol Biochem. 2016;39(3):827-36. doi: 10.1159/000447793. Epub 2016 Aug 9. Cell Physiol Biochem. 2016. PMID: 27497782 Free article.

3

Manipulating PML SUMOylation via Silencing UBC9 and RNF4 Regulates Cardiac Fibrosis.

Liu Y, Zhao D, Qiu F, Zhang LL, Liu SK, Li YY, Liu MT, Wu D, Wang JX, Ding XQ, Liu YX, Dong CJ, Shao XQ, Yang BF, Chu WF. Liu Y, et al. Among authors: liu mt, liu sk, liu yx. Mol Ther. 2017 Mar 1;25(3):666-678. doi: 10.1016/j.ymthe.2016.12.021. Epub 2017 Jan 28. Mol Ther. 2017. PMID: 28143738 Free PMC article.

4

Arsenic trioxide and angiotensin II have inhibitory effects on HERG protein expression: Evidence for the role of PML SUMOylation.

Liu Y, Li D, Nie D, Liu SK, Qiu F, Liu MT, Li YY, Wang JX, Liu YX, Dong CJ, Wu D, Tian W, Yang J, Mu W, Li JT, Zhao D, Wang XF, Chu WF, Yang BF. Liu Y, et al. Among authors: liu mt, liu sk, liu yx. Oncotarget. 2017 Jul 11;8(28):45447-45458. doi: 10.18632/oncotarget.17563. Oncotarget. 2017. PMID: 28525371 Free PMC article.

5

Pharmacological inhibition of SUMO-1 with ginkgolic acid alleviates cardiac fibrosis induced by myocardial infarction in mice.

Qiu F, Dong C, Liu Y, Shao X, Huang D, Han Y, Wang B, Liu Y, Huo R, Paulo P, Zhang ZR, Zhao D, Chu WF. Qiu F, et al. Toxicol Appl Pharmacol. 2018 Apr 15;345:1-9. doi: 10.1016/j.taap.2018.03.006. Epub 2018 Mar 7. Toxicol Appl Pharmacol. 2018. PMID: 29524504

6

Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report.

Liu Y, Dong C, He X, Wu P, Shu Y, Chen L. Liu Y, et al. BMC Nephrol. 2023 Mar 10;24(1):51. doi: 10.1186/s12882-023-03101-9. BMC Nephrol. 2023. PMID: 36899322 Free PMC article.

7

Postischemic administration of Z-Ligustilide ameliorates cognitive dysfunction and brain damage induced by permanent forebrain ischemia in rats.

Kuang X, Du JR, Liu YX, Zhang GY, Peng HY. Kuang X, et al. Among authors: liu yx. Pharmacol Biochem Behav. 2008 Jan;88(3):213-21. doi: 10.1016/j.pbb.2007.08.006. Epub 2007 Aug 24. Pharmacol Biochem Behav. 2008. PMID: 17889286

8

Neuroprotective effect of Z-ligustilide against permanent focal ischemic damage in rats.

Peng HY, Du JR, Zhang GY, Kuang X, Liu YX, Qian ZM, Wang CY. Peng HY, et al. Among authors: liu yx. Biol Pharm Bull. 2007 Feb;30(2):309-12. doi: 10.1248/bpb.30.309. Biol Pharm Bull. 2007. PMID: 17268071 Free article.

9

Experimental realization of on-chip few-photon control around exceptional points.

Song P, Ruan X, Ding H, Li S, Chen M, Huang R, Kuang LM, Zhao Q, Tsai JS, Jing H, Yang L, Nori F, Zheng D, Liu YX, Zhang J, Peng Z. Song P, et al. Among authors: liu yx. Nat Commun. 2024 Nov 14;15(1):9848. doi: 10.1038/s41467-024-54199-w. Nat Commun. 2024. PMID: 39537631 Free PMC article.

10

Inflammatory index is a promising biomarker for maintenance hemodialysis patients with cardiovascular disease.

Han XX, Zhang HY, Kong JW, Liu YX, Zhang KR, Ren WY. Han XX, et al. Among authors: liu yx. Eur J Med Res. 2024 Nov 13;29(1):544. doi: 10.1186/s40001-024-02117-7. Eur J Med Res. 2024. PMID: 39533444 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,747 results

Search Page

Filters